Literature DB >> 18574736

Tumor promoting or tumor suppressing of NF-kappa B, a matter of cell context dependency.

Fei Chen1, Kevin Beezhold, Vince Castranova.   

Abstract

Nuclear factor-kappa B (NF-kappa B) and its activating signaling pathways are critical regulators for cell lineage development, growth, differentiation, apoptosis, and tumorigenic transformation. As one of the most important transcription factors, NF-kappa B has been implicated in the transcriptional upregulation of a number of cytokines, adhesion molecules, growth factors, oncogenes, antiapoptotic proteins, some proapoptotic factors, and even certain viral genes. The role of NF-kappa B on tumor promoting has been well-documented in the past two decades. However, during the past few years, a considerable number of studies suggested that NF-kappa B and its activating signaling molecules may act as tumor suppressors under some circumstances. Thus, it is highly possible that tumor promoting or tumor suppressing of NF-kappa B signaling is determined by the type of cells, stimuli, simultaneous or asynchronous intracellular signals, and other cellular contexts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574736     DOI: 10.1080/08830180802130327

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  14 in total

1.  Does NEMO/IKKγ protein have a role in determining prognostic significance in uveal melanoma?

Authors:  M K Singh; N Pushker; R Meel; K Chodsol; S Sen; S Bakhshi; L Singh; S Kashyap
Journal:  Clin Transl Oncol       Date:  2018-05-23       Impact factor: 3.405

2.  Potential role of bromelain in clinical and therapeutic applications.

Authors:  Vidhya Rathnavelu; Noorjahan Banu Alitheen; Subramaniam Sohila; Samikannu Kanagesan; Rajendran Ramesh
Journal:  Biomed Rep       Date:  2016-07-18

Review 3.  High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility?

Authors:  Cagatay Oktenli; Serkan Celik
Journal:  Int J Hematol       Date:  2012-03-28       Impact factor: 2.490

4.  Prognostic significance of kappaB-Ras1 expression in gliomas.

Authors:  Hong Lin; Yangang Wang; Xiang Zhang; Bolin Liu; Wei Zhang; Jinxiang Cheng
Journal:  Med Oncol       Date:  2011-02-08       Impact factor: 3.064

5.  Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.

Authors:  Sima Z Torabian; David de Semir; Mehdi Nosrati; Sepideh Bagheri; Altaf A Dar; Sylvia Fong; Yong Liu; Scot Federman; Jeff Simko; Chris Haqq; Robert J Debs; Mohammed Kashani-Sabet
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

6.  Quercetin enhances the effects of 5-fluorouracil-mediated growth inhibition and apoptosis of esophageal cancer cells by inhibiting NF-κB.

Authors:  Lu Chuang-Xin; Wang Wen-Yu; Cui Yao; Li Xiao-Yan; Zhou Yun
Journal:  Oncol Lett       Date:  2012-07-27       Impact factor: 2.967

7.  NSCLC and the alternative pathway of NF-κB: uncovering an unknown relation.

Authors:  Fotinos-Ioannis D Dimitrakopoulos; Anna G Antonacopoulou; Anastasia Kottorou; Helen Vlotinou; Nikolaos D Panagopoulos; Dimitrios Dougenis; Chrisoula Scopa; Helen Papadaki; Haralabos P Kalofonos
Journal:  Virchows Arch       Date:  2012-05-05       Impact factor: 4.064

8.  Inhibition of NF-κB activation sensitizes U937 cells to 3'-azido-3'-deoxythymidine induced apoptosis.

Authors:  C Matteucci; A Minutolo; E Balestrieri; F Marino-Merlo; P Bramanti; E Garaci; B Macchi; A Mastino
Journal:  Cell Death Dis       Date:  2010-10-07       Impact factor: 8.469

9.  Nonlinear dependencies of biochemical reactions for context-specific signaling dynamics.

Authors:  Myong-Hee Sung; Gordon L Hager
Journal:  Sci Rep       Date:  2012-08-31       Impact factor: 4.379

10.  Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist.

Authors:  Zhiqiang Hu; Yaling Xing; Yuanyu Qian; Xiaojuan Chen; Jian Tu; Lening Ren; Kai Wang; Zhongbin Chen
Journal:  J Radiat Res       Date:  2012-10-26       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.